Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis B or C: A Systematic Review and Meta-Analysis

Figure 5

Forest plots depicting pooled mOS of (a) uninfected patients and patients with HCV and HBV and (b) patients with hepatitis.

(a)

(b)